Skip to content
healthcare.dev
Get a free key

TASCENSO ODT

NDC 70709-062, Fingolimod Lauryl Sulfate, tablet, orally disintegrating, from Cycle Pharmaceuticals Ltd.

Product NDC
70709-062
Status
Listed
Labeler
Cycle Pharmaceuticals Ltd
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214962
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70709-062 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FINGOLIMOD LAURYL SULFATE.25 mg/1

Pharmacologic classes

Sphingosine 1-Phosphate Receptor Modulators [MoA]; Sphingosine 1-phosphate Receptor Modulator [EPC]

Package NDCNDC-11Package
70709-062-30707090062303 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bf8e7f89-ea09-43c7-a7eb-e44724350721

Use it

Look up 70709-062 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70709-062 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70709-062. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.